MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Anxiety"

  • MDS Virtual Congress 2020

    Insomnia may have a mediating role in linking Parkinson’s disease severity to depression and anxiety

    G. Yeganyan, S. Khachatryan, Z. Tavadyan (Yerevan, Armenia)

    Objective: The aim of this study was to investigate the role of insomnia in relationship of disease severity with depression/anxiety in patients with Parkinson’s disease…
  • MDS Virtual Congress 2020

    Anxiety in Parkinson’s disease is associated with changes in the brain fear circuit

    G. Carey, R. Lopes, R. Viard, N. Betrouni, G. Kuchcinski, Q. Devignes, L. Defebvre, A. Leentjens, K. Dujardin (Lille, France)

    Objective: The aim of this study was to identify the anatomical and functional changes related to anxiety, especially in the “fear circuit”, by comparing PD…
  • 2019 International Congress

    Predictors of Health-Related Quality of Life in Patients with Cervical Dystonia

    SA. Reijneveld, Z. Gdovinova, MAJ. Tijssen, JP. van Dijk, T. Hoekstra, M. Turcanova Koprusakova, M. Smit, M. Skorvanek, V. Han (Martin, Slovakia)

    Objective: The aim of our study was to assess the prevalence of non-motor symptoms (NMS) and to explore their association with health-related quality of life…
  • 2019 International Congress

    Alexander Technique Group Classes Are a Feasible and Promising Intervention for Care Partners of People living with Parkinson’s disease

    M. Gross, R. Ravichandra, B. Mello, R. Cohen (Candler, NC, USA)

    Objective: To test an adapted Alexander technique (AT) group course to improve quality of life for care partners of people living with Parkinson’s disease (PLwPD).…
  • 2019 International Congress

    Repetitive transcranial magnetic stimulation can improve anxiety in Parkinson’s disease: a randomized, double-blind and controlled trial

    A. Makkos-Weisz, N. Kovács, P. Endre, M. Kovács, D. Pintér (Pécs, Hungary)

    Objective: High frequrncy (HF) repetitive transcranial magnetic stimulation (rTMS) improve anxiety in Parkinson’s Disease (PD). Background: The high frequency repetitive transcranial magnetic stimulation above the…
  • 2019 International Congress

    Prefrontal cortex high beta power correlates with the severity of anxiety and depression in Parkinson’s disease patients

    C. de Hemptinne, W. Chen, C. Racine, A. Seritan, J. Mergenthaler, S. Rajagopalan, J. Ostrem, P. Starr (San Francisco, CA, USA)

    Objective: To investigate the neural correlates of anxiety and depression in PD patients and to develop a novel neurostimulation therapy for these non-motor symptoms. Background:…
  • 2019 International Congress

    Quality of life in isolated dystonia – a cross-sectional study

    J. Junker, B. Berman, D. Wahba, J. Hall, J. Perlmutter, J. Jankovic, I. Malaty, V. Brandt, S. Reich, A. Espay, N. Patel, E. Roze, M. Vidailhet, H. Jinnah, N. Brueggemann (Luebeck, Germany)

    Objective: To evaluate the relationship between health-related quality of life (HR-QoL) and both physical and psychiatric factors in a large, international, multi-centre cohort of isolated…
  • 2019 International Congress

    Predictors of quality of life in dystonia – a longitudinal study

    J. Junker, J. Hall, B. Berman, M. Vidailhet, E. Roze, I. Malaty, J. Jankovic, S. Reich, A. Espay, N. Patel, J. Perlmutter, H. Jinnah, V. Brandt, N. Brueggemann (Luebeck, Germany)

    Objective: To determine the impact of physical and psychiatric morbidity on health-related quality of life (HR-QoL) in a large, international, multi-centre cohort of isolated dystonia…
  • 2019 International Congress

    Depression, Anxiety and Sleep Disturbances in Patients with Craniocervical Dystonias

    Z. Khayatova, Z. Zalyalova (Kazan, Russian Federation)

    Objective: This study aimed to examine whether botulinum neurotoxin (BT) treatment affects nonmotor symptoms of dystonia, particularly depression (D), anxiety (A) and sleep disturbances (SD)…
  • 2019 International Congress

    Domain-specific impact of mood/anxiety disorders on quality of life in idiopathic dystonia

    D. Martino, Y. Jasaui, J. Sarna, S. Furtado, S. Patten, T. Pringsheim (Calgary, AB, Canada)

    Objective: To evaluate the relationship between mood/anxiety disorder severity and quality of life (QoL) domains in adult-onset idiopathic dystonia (AOID). Background: Depression and anxiety exert…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 19
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley